A. Seleznev

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

V. Mazurov, O. Moiseeva, M. Gilyarov, 2021, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

POS1214 THE DYNAMICS OF INFLAMMATORY MARKERS IN COVID-19 PATIENTS TREATED WITH LEVILIMAB

V. Mazurov, O. Moiseeva, M. Gilyarov, 2021, Annals of the Rheumatic Diseases.